Jin Ren
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 9
- RNA modifications and cancer 9
- RNA Interference and Gene Delivery 9
-
- MicroRNA in disease regulation 22
- Cancer-related molecular mechanisms research 12
- Co-authors
- Xinming Qi (49 shared papers)Lingling Miao (12 shared papers)Likun Gong (34 shared papers)Yizheng Wang (6 shared papers)Zhouteng Tao (9 shared papers)Xiang Xue (14 shared papers)Jing Chen (4 shared papers)Ying Xiao (14 shared papers)
- Journals
- Acta Pharmacologica Sinica (15 papers)Toxicology Letters (4 papers)Neurochemical Research (3 papers)Journal of Ethnopharmacology (3 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jin Ren
136 papers receiving 3.5k citations
Jin Ren's Hit Papers
Peers
Comparison fields: 5 of 143
- Pharmacology 614
- Cancer Research 894
- Complementary and alternative medicine 233
- Molecular Biology 1.6k
- Analytical Chemistry 191
Countries citing papers authored by Jin Ren
This map shows the geographic impact of Jin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Ren more than expected).
Fields of papers citing papers by Jin Ren
This network shows the impact of papers produced by Jin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Ren. The network helps show where Jin Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression Hit paper breakdown → | 2018 | 360 |
| 2 | 2016 | 80 | |
| 3 | 2007 | 79 | |
| 4 | 2016 | 78 | |
| 5 | 2011 | 72 | |
| 6 | 2017 | 69 | |
| 7 | 2008 | 68 | |
| 8 | 2010 | 65 | |
| 9 | 2017 | 63 | |
| 10 | 2011 | 63 | |
| 11 | 2007 | 61 | |
| 12 | 2018 | 61 | |
| 13 | 2020 | 58 | |
| 14 | 2010 | 51 | |
| 15 | 2013 | 50 | |
| 16 | 2011 | 49 | |
| 17 | 2011 | 49 | |
| 18 | 2016 | 47 | |
| 19 | 2006 | 45 | |
| 20 | 2020 | 44 |
About Jin Ren
Jin Ren is a scholar working on Molecular Biology, Cancer Research, Pharmacology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 138 papers that have together received 3.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (22 papers), Drug-Induced Hepatotoxicity and Protection (19 papers), Nephrotoxicity and Medicinal Plants (14 papers), Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (9 papers), RNA modifications and cancer (9 papers), RNA Interference and Gene Delivery (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Pharmacology (614 citations), Cancer Research (894 citations), Complementary and alternative medicine (233 citations), Molecular Biology (1.6k citations) and Analytical Chemistry (191 citations). Jin Ren has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xinming Qi, Lingling Miao, Likun Gong, Yizheng Wang, Zhouteng Tao, Xiang Xue, Jing Chen, Ying Xiao, Yang Luan and Guozhen Xing. Their work appears in journals such as Acta Pharmacologica Sinica, Toxicology Letters, Neurochemical Research, Journal of Ethnopharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.